TRERF1 and Alzheimer disease: The expression of LC3 II increased in Rapa (p < 0.05 vs. AD), LG-H (p < 0.01 vs. AD), LG-H + 3-MA (p < 0.05 vs. AD) and LG-M (p < 0.05 vs. AD) groups, and decreased in LG-H + 3-MA (p < 0.01 vs. LG-H) and LG-M + 3-MA (p < 0.01 vs. LG-M) groups.